IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT04849325
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Registry
-
NCT04849325
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04849325. Randomized; single masking; primary purpose treatment. Start 2021-12-09 (actual); primary completion 2024-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease
- Acronym
- GENIUS
- Condition
- Critical Limb Ischemia (CLI)
- Intervention (Device)
- Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan™)
- Intervention (Device)
- Percutaneous Transluminal Angioplasty (PTA) Device
- Lead sponsor
- Biotyx Medical (Shenzhen) Co., Ltd.
Record details
- Record id
cardio:ct-nct04849325- Content hash
2936013fb0e43b0e2a393330f4e0c7c0167fc2bc02c14a090828ace70536291d